发明名称 |
Use of combination preparations comprising antifungal agents |
摘要 |
The invention relates to the use of an antimycotic agent and an epithelial cell or endothelial cell adhesion inhibitor for producing a combination drug for the topical treatment of Candida mycoses selected from vulvovaginal candidiasis, oropharyngeal candidiasis (oral thrush), diaper dermatitis (diaper thrush) and intertriginous (Candida) eczema. |
申请公布号 |
US8815925(B2) |
申请公布日期 |
2014.08.26 |
申请号 |
US201314044532 |
申请日期 |
2013.10.02 |
申请人 |
|
发明人 |
Noe Christian;Noe-Letschnig Marion |
分类号 |
A61K31/41;A61K31/415;A61K31/45;A61K31/195;A61K31/196;A61K31/4164;A61K45/06;A61K31/4174 |
主分类号 |
A61K31/41 |
代理机构 |
Fulbright & Jaworski LLP |
代理人 |
Fulbright & Jaworski LLP |
主权项 |
1. A method of treating a Candida mycosis further defined as vulvovaginal candidiasis, oropharyngeal candidiasis (oral thrush), diaper dermatitis (diaper thrush), and/or intertriginous eczema comprising:
obtaining a combination drug comprising an antimycotic agent and an epithelial cell or endothelial cell adhesion inhibitor; and topically treating a subject having a Candida mycosis further defined as vulvovaginal candidiasis, oropharyngeal candidiasis, diaper dermatitis, and/or intertriginous eczema with the combination drug, wherein the epithelial cell or endothelial cell adhesion inhibitor is further defined as: a non-steroidal antiphlogistic agent (NSAID) having a sufficient COX1-inhibition, defined by the exclusion of compounds having a COX1/COX2 ratio (IC50, microM) of >20; a prostacyclin or a prostacyclin analogue; or an inhibitor of the expression of epithelial and endothelial adhesion molecules. |
地址 |
Vienna AT |